Delivering extraordinary. Empowering ordinary.
We’re developing novel oral medicines for rare diseases to help patients take part in the everyday activities they enjoy.Learn More
Structure-guided Drug Design
We combine traditional cell biology with medicinal chemistry to build synthetic compounds that bind to specific protein targets to fight disease.See Our Science
Building a Rare Disease Drug Portfolio
We are developing a pipeline of oral drugs for rare diseases.View Our Pipeline
Stay up to date with the latest discoveries, events, and reports from BioCryst.
VIEW ALL PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BioCryst Presents New Long-term and Real-world Data Demonstrating Sustained Reductions in Hereditary Angioedema Attack Rates and Improvement in Quality of Life with ORLADEYO® (berotralstat)
BioCryst to Present at Upcoming Investor Conferences
Join Our Team
We are a collection of passionate individuals united by a commitment to scientific excellence and an unwavering focus on the needs of patients.JOB OPENINGS